Pieris Pharmaceuticals
PIRS
#9970
Rank
โ‚ฌ16.34 M
Marketcap
12,38ย โ‚ฌ
Share price
-15.58%
Change (1 day)
-3.60%
Change (1 year)

Earnings for Pieris Pharmaceuticals (PIRS)

Earnings in 2024 (TTM): -โ‚ฌ20.62 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ19.57 Million. In 2022 the company made an earning of -โ‚ฌ30.3 Million, an increase over its 2021 earnings that were of -โ‚ฌ41.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Pieris Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ20.62 Million
2022 -โ‚ฌ30.3 Million-27.24%
2021 -โ‚ฌ41.64 Million23.4%
2020 -โ‚ฌ33.75 Million45.53%
2019 -โ‚ฌ23.19 Million-5.89%
2018 -โ‚ฌ24.64 Million63.59%
2017 -โ‚ฌ15.07 Million-26.92%
2016 -โ‚ฌ20.61 Million63.39%
2015 -โ‚ฌ12.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ72.28 Million 258.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ5 Million-75.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.62 B-3,219.21%๐Ÿ‡บ๐Ÿ‡ธ USA